Primary Site >> Liver Cancer
Gene >> TGFB1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Hepatic silicosis, cirrhosis, and liver tumors in mice and hamsters: studies of transforming growth factor beta expression. PMID: 8621163 |
Ref: Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity. PMID: 10200566 |
Ref: Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo. PMID: 10675495 Ref: Secretion of extracellular matrix (fibronectin), growth factor (transforming growth factor beta) and protease (cathepsin D) by hepatoma cells. PMID: 10765130 |
Ref: Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cells. PMID: 11238185 |
Ref: Expression of activins C and E induces apoptosis in human and rat hepatoma cells. PMID: 12949049 |
Ref: [The study of inhibition effect of octreotide on the growth of hepatocellular carcinoma xenografts in situ in nude mice]. PMID: 16008961 Ref: [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance]. PMID: 16083599 |
Ref: Dysregulation of growth factor signaling in human hepatocellular carcinoma. PMID: 16799620 Ref: Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. PMID: 17261758 |
Ref: Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors. PMID: 18282651 |
Ref: Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis. PMID: 19854227 Ref: Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. PMID: 20196115 Ref: Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. PMID: 20942864 |
Ref: Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival. PMID: 21104785 |
Ref: TGF-beta-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. PMID: 23034213 |
Ref: The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling. PMID: 23109092 Ref: Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. PMID: 23174907 Ref: Evaluation of TGFbeta, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC. PMID: 23251252 Ref: KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. PMID: 23504025 Ref: iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models. PMID: 24223834 |
Ref: Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases. PMID: 24797128 Ref: Summary of bi-shRNA/GM-CSF augmented autologous tumor cell immunotherapy (FANG) in advanced cancer of the liver. PMID: 24968881 Ref: Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells. PMID: 25098666 |
Ref: A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. PMID: 25478810 Ref: Co-migration of colon cancer cells and CAFs induced by TGFbeta(1) enhances liver metastasis. PMID: 25557989 Ref: Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma. PMID: 25820415 Ref: The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis. PMID: 25879842 Ref: The role of TGFBI (betaig-H3) in gastrointestinal tract tumorigenesis. PMID: 25889002 Ref: Monoclonal antibody against transforming growth factor Beta 1 does not influence liver regeneration after resection in large animal experiments. PMID: 25977378 Ref: A Long Non-coding RNA Activated by Transforming Growth Factor-beta is an Independent Prognostic Marker of Gastric Cancer. PMID: 25986864 Ref: Effects of transforming growth factor beta-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma. PMID: 26003220 |
Ref: NIM811 downregulates transforming growth factorbeta signal transduction in vivo and in vitro. PMID: 26573209 Ref: Differential TGFbeta pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. PMID: 26987776 Ref: miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. PMID: 27073326 Ref: Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis. PMID: 27835897 |
Ref: Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. PMID: 27923447 Ref: Transforming growth factor-beta-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. PMID: 28161507 Ref: Tumor-Associated Neutrophils and Macrophages Promote Gender Disparity in Hepatocellular Carcinoma in Zebrafish. PMID: 28202512 Ref: Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma. PMID: 28333958 Ref: The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. PMID: 28432618 Ref: Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma. PMID: 28462385 Ref: Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFbeta inhibitors to hepatocellular carcinoma cells. PMID: 28685231 Ref: Genetic variants underlying vitamin D metabolism and VDR-TGFbeta-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study. PMID: 28703134 Ref: The level of caveolin-1 expression determines response to TGF-beta as a tumour suppressor in hepatocellular carcinoma cells. PMID: 29022911 Ref: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish. PMID: 29100373 |
Ref: Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. PMID: 29402900 Ref: Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. PMID: 29692627 Ref: External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery. PMID: 29724129 Ref: Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish. PMID: 29855567 Ref: Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells. PMID: 30081711 Ref: Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis. PMID: 30097285 Ref: Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress. PMID: 30109568 Ref: Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocarcinogenesis via modulating TGF-beta/TbetaR and Imp7/8. PMID: 30112050 Ref: Bclaf1 promotes angiogenesis by regulating HIF-1alpha transcription in hepatocellular carcinoma. PMID: 30367150 |